RITTER PHARMACEUTICALS INC·4

Mar 13, 6:13 PM ET

Ritter Andrew J 4

4 · RITTER PHARMACEUTICALS INC · Filed Mar 13, 2020

Insider Transaction Report

Form 4
Period: 2020-03-04
Ritter Andrew J
DirectorPresident
Transactions
  • Sale

    Common Stock

    2020-03-04$0.38/sh18,750$7,04381,727 total(indirect: By LLC)
Holdings
  • Common Stock

    625
Footnotes (1)
  • [F1]As a managing partner of Stonehenge Partners LLC, the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT